Clinical trial
Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The…
NCT00404547 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00404547 |
|---|---|
| Title | Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102) |
| Official title | An Open-Label Randomized, Multicenter Study in Patients With Asthma to Evaluate the Effectiveness of Alvesco® (Ciclesonide) Compared to Asthma Usual Care in a Primary Practice Setting |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Ciclesonide, Usual Care Inhaled Glucocorticosteroids |
| Enrollment | 1,121 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Nov 28, 2006 |
| Last update posted | Feb 1, 2017 |
| Countries | Canada |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: